| Literature DB >> 20621566 |
Luisa M Villar1, Mercedes Espiño, María L Cavanillas, Ernesto Roldán, Elena Urcelay, Emilio G de la Concha, Maria C Sádaba, Rafael Arroyo, Pedro González-Porqué, José C Alvarez-Cermeño.
Abstract
We described previously that multiple sclerosis (MS) patients with oligoclonal IgM against myelin lipids (M+) develop an aggressive disease. Our aim was to assess possible mechanisms regulating the production of these antibodies. We studied B cell subsets in 180 patients with MS, and 69 with other neurological diseases. M+ MS patients showed a moderate increase of CD5(+) B-cell percentage in peripheral blood and a considerable augment of these cells in cerebrospinal fluid (CSF) that correlated with intrathecal IgM production. The appearance of CD5(+) B cells into the central nervous system (CNS) was related to increased CXCL13 and TNF-alpha levels in CSF. Moreover, the presence of oligoclonal IgM associated with a SNP at position -376 of the TNF-alpha promoter. These results help to elucidate the B lymphocytes responsible for intrathecal IgM secretion in MS and the origin of this abnormal B-cell response in patients with aggressive MS.Entities:
Mesh:
Substances:
Year: 2010 PMID: 20621566 DOI: 10.1016/j.clim.2010.06.007
Source DB: PubMed Journal: Clin Immunol ISSN: 1521-6616 Impact factor: 3.969